The Summer 2024 edition of the NIHR UCLH Clinical Research Facility’s (CRF) early phase cancer trials newsletter is out now.
In this edition:
- Managing Director of Research at UCLH/UCL Dr Nick McNally writes about the crucial role the CRF at UCLH plays in early phase trials in cancer
- CRF Principal Investigator Dr Elisavet Papadimitraki provides an overview of the CRF’s growing early phase trials portfolio in breast cancer
- Consultant medical oncologist Professor Sandra Strauss summarises results of a new kind of academic trial in a rare type of bone cancer, presented at the American Society of Clinical Oncology (ASCO) meeting 2024
- The CRF team reports back from the 19th UK CRF Network Conference 2024
- And more.
